Skip to main content
Top
Published in: BMC Geriatrics 1/2023

Open Access 01-12-2023 | COVID-19 | Research

The impact of COVID-19 on the mental health of older sexual minority Canadians in the CLSA

Authors: Alexandra Grady, Arne Stinchcombe

Published in: BMC Geriatrics | Issue 1/2023

Login to get access

Abstract

Purpose

Limited research has examined the mental health impacts of the COVID-19 pandemic on sexual minority (i.e., lesbian, gay, bisexual; LGB) older adults using a longitudinal approach. This study aimed to compare the mental health trajectories (i.e., reported symptoms of depression and loneliness) of LGB and heterosexual participants across four time points.

Methods

Data were drawn from the Canadian Longitudinal Study on Aging (CLSA), an ongoing study on the experiences of adults between 45 to 85 at Baseline. Data included for analysis were collected at Baseline (2011-2015), Follow-up 1 (2015-2018), and two time points during the COVID-19 pandemic (April-December 2020). We used General Estimating Equations (GEE) to model changes in depression symptoms (CESD-10; n = 47,728) and loneliness (UCLA 3-item loneliness scale; n = 41,698), adjusting for covariates (i.e., age, sex, race/ethnicity, education, and income).

Results

Results indicated that LGB participants reported more symptoms of depression (B = .595, p < .001) and loneliness (B = .313, p < .001) in comparison to heterosexual peers across the four time points. Mean depression and loneliness scores increased regardless of sexual orientation.

Conclusion

This study highlighted the detrimental effects of the pandemic on the mental health of older adults regardless of sexual orientation. It also showed that LGB older adults experienced more loneliness and depression symptoms than heterosexual older adults both before and during the pandemic. Understanding diverse identities, needs, and disparities in mental health is critical to promoting equitable aging experiences for everyone.
Literature
6.
go back to reference Canadian Institute for Health Information. COVID-19 Intervention Scan - Data Tables. 2022. Canadian Institute for Health Information. COVID-19 Intervention Scan - Data Tables. 2022.
10.
17.
19.
go back to reference Brooks VR. Minority stress and lesbian women. Lexington, Mass: Lexington Books; 1981. Brooks VR. Minority stress and lesbian women. Lexington, Mass: Lexington Books; 1981.
25.
go back to reference Andresen E, Malmgren J, Carter W, et al. Screening for depression in well older adults: evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale). Am J Prev Med. 1994;10(2):77–84.CrossRefPubMed Andresen E, Malmgren J, Carter W, et al. Screening for depression in well older adults: evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale). Am J Prev Med. 1994;10(2):77–84.CrossRefPubMed
29.
go back to reference StataCorp. Stata Statistical Software. 2017. StataCorp. Stata Statistical Software. 2017.
32.
go back to reference World Health Organization. COVID-19 and the social determinants of health and health equity: evidence brief. Geneva: World Health Organization; 2021. World Health Organization. COVID-19 and the social determinants of health and health equity: evidence brief. Geneva: World Health Organization; 2021.
Metadata
Title
The impact of COVID-19 on the mental health of older sexual minority Canadians in the CLSA
Authors
Alexandra Grady
Arne Stinchcombe
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Geriatrics / Issue 1/2023
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/s12877-023-04513-w

Other articles of this Issue 1/2023

BMC Geriatrics 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine